What changed from existing technology?
This study found that a protein called s-SHIP is linked to drug resistance in some breast cancer cells, which could help in developing better treatments for aggressive breast cancer.
This study identifies PIERCE1 as a new gene associated with drug resistance in breast cancer cells, which was not previously known.
Commercialization signals visible at publication
This is not a success probability or investment opinion. It prioritizes follow-up using evidence available when the paper was published.
Verified evidence · 0
- 시제품·장치 구현 근거 미확인
- 제조·규모 확장 근거 미확인
- 장기·실사용 검증 근거 미확인
Later patent, company, clinical, and production events are added separately only after verification.
Patent check: Not checked yetCurrent technology stage: Near commercialization
See what changed before reading the full paper.
What still needs to be solved?
Repeated real-world validation, manufacturability, cost, and long-term stability still require follow-up evidence.
What could change if this succeeds?
This finding could help in developing targeted therapies for breast cancer patients who develop resistance to chemotherapy.
Keep following this technology
Revisit changes when new papers, patents, company participation, validation, or products appear.